Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 22^nd Annual Global Healthcare Conference in New York, NY.